Repligen
RGEN
#2061
Rank
NZ$15.96 B
Marketcap
NZ$283.56
Share price
-0.42%
Change (1 day)
8.99%
Change (1 year)
Categories

Earnings for Repligen (RGEN)

Earnings in 2025 (TTM): NZ$42.04 Million

According to Repligen 's latest financial reports the company's current earnings are NZ$0.70 Billion. In 2024 the company made an earning of -NZ$10.8 Million a decrease over its 2023 earnings that were of NZ$82.93 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Repligen from 1985 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$42.04 M-489.64%
2024 -NZ$10.8 Million-113.01%
2023 NZ$82.93 M-78.01%
2022 NZ$0.37 B33.37%
2021 NZ$0.28 B131.52%
2020 NZ$0.12 B101.31%
2019 NZ$60.66 M25.93%
2018 NZ$48.17 M105.61%
2017 NZ$23.43 M-11.46%
2016 NZ$26.46 M14.91%
2015 NZ$23.03 M20.26%
2014 NZ$19.15 M-51.49%
2013 NZ$39.47 M90.98%
2012 NZ$20.67 M
2010 NZ$0.29 M-103.81%
2009 -NZ$7.86 Million-223.84%
2008 NZ$6.34 M
2006 -NZ$4.26 Million229.64%
2005 -NZ$1.3 Million-89.16%
2004 -NZ$11.93 Million-16.86%
2003 -NZ$14.35 Million88.72%
2002 -NZ$7.6 Million-27.88%
2001 -NZ$10.54 Million-1.74%
2000 -NZ$10.73 Million85.93%
1999 -NZ$5.77 Million159.16%
1998 -NZ$2.23 Million85.71%
1997 -NZ$1.2 Million-70.83%
1996 -NZ$4.11 Million-72.41%
1995 -NZ$14.9 Million-60.63%
1994 -NZ$37.83 Million45.39%
1993 -NZ$26.02 Million39.45%
1992 -NZ$18.66 Million-32.3%
1991 -NZ$27.56 Million6.62%
1990 -NZ$25.85 Million1577.78%
1989 -NZ$1.55 Million-57.14%
1988 -NZ$3.6 Million-362.5%
1987 NZ$1.36 M-130.77%
1986 -NZ$4.46 Million136.36%
1985 -NZ$1.89 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novavax
NVAX
NZ$0.64 B 1,334.44%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$1.16 B 2,498.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
NZ$0.99 B 2,130.89%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
NZ$17.56 B 39,143.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
NZ$12.14 B 27,044.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$13.75 B 30,628.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$20.28 B 45,237.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
NZ$0.19 B 342.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-NZ$0.19 Billion-517.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
-NZ$38 Million-184.90%๐Ÿ‡บ๐Ÿ‡ธ USA